Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP

Last updated on 2024-12-10 History
Report ID 78454
Drug Identification Number 02387468
Brand name LABETALOL HYDROCHLORIDE INJECTION, USP
Common or Proper name LABETALOL HYDROCHLORIDE INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML 1VL
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-05-05
Estimated end date
Actual end date 2023-01-10
Shortage status Resolved
Updated date 2024-12-10
Company comments ID 10718 was resolved in error on Mar-8-2019. Reopened report in this ID. Original 'Actual Start Date' of 2018-05-05 was used.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v64 2024-12-10 French Compare
v63 2024-12-10 English Compare
v62 2020-04-23 French Compare
v61 2020-04-23 English Compare
v60 2020-04-23 French Compare
v59 2020-04-23 English Compare
v58 2019-09-11 English Compare
v57 2019-09-03 French Compare
v56 2019-09-03 English Compare
v55 2019-08-30 French Compare
v54 2019-08-30 English Compare
v53 2019-08-30 English Compare
v52 2019-08-23 French Compare
v51 2019-08-23 English Compare
v50 2019-08-15 English Compare
v49 2019-08-14 French Compare
v48 2019-08-14 English Compare
v47 2019-08-08 English Compare
v46 2019-08-07 French Compare
v45 2019-08-07 English Compare

Showing 1 to 20 of 64